Michaela Kreiner

Title: Michaela Kreiner: Patent Work in Pharmaceutical Innovation.

Introduction

Michaela Kreiner is an inventor associated with pharmaceutical research and patent activity in Glasgow, Great Britain. Her listed patent concerns salts and polymorphic forms of a compound investigated for its potential role in treating cancer and other diseases.

Latest Patents

Kreiner is associated with 1 patent: “Salts and polymorphic forms of 6-chloro-7-(4-(4-chlorobenzyl)piperazin-1-yl)-2-(1,3-dimethyl-1H-pyrazol-4-yl)-3H-imidazo[4,5-b]pyridine.” The invention covers salts and polymorphic forms of Compound A, an inhibitor of Aurora kinase and FMS-like tyrosine kinase 3 (FLT3) activity. It also describes methods for preparing these forms, pharmaceutical compositions containing them, and their potential use in treating proliferative disorders such as cancer, along with other conditions in which Aurora kinase or FLT3 activity is implicated.

Career Highlights

The supplied information associates Kreiner with Ellipses Pharma Limited and the Institute of Cancer Research: Royal Cancer Hospital. Her patent work reflects research into the development and pharmaceutical preparation of compounds targeting kinase activity.

Collaborations

Kreiner’s listed coworkers include Jonathan Loughrey and Gavin Halbert. Their names are associated with the collaborative research context surrounding her patent activity.

Conclusion

Michaela Kreiner’s recorded invention focuses on pharmaceutical forms and preparation methods for a compound with potential applications in cancer and other disease treatment.